Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies

N Chakraborty, D Jha, I Roy, P Kumar… - Journal of …, 2022 - Springer
Given the spasmodic increment in antimicrobial resistance (AMR), world is on the verge of
“post-antibiotic era”. It is anticipated that current SARS-CoV2 pandemic would worsen the …

Understanding modern-day vaccines: what you need to know

V Vetter, G Denizer, LR Friedland, J Krishnan… - Annals of …, 2018 - Taylor & Francis
Vaccines are considered to be one of the greatest public health achievements of the last
century. Depending on the biology of the infection, the disease to be prevented, and the …

Viral emerging diseases: challenges in developing vaccination strategies

M Trovato, R Sartorius, L D'Apice, R Manco… - Frontiers in …, 2020 - frontiersin.org
In the last decades, a number of infectious viruses have emerged from wildlife or re-
emerged, generating serious threats to the global health and to the economy worldwide …

Increased risk of influenza among vaccinated adults who are obese

SD Neidich, WD Green, J Rebeles… - International journal of …, 2017 - nature.com
Background: Influenza infects 5–15% of the global population each year, and obesity has
been shown to be an independent risk factor for increased influenza-related complications …

Biological sex affects vaccine efficacy and protection against influenza in mice

AL Fink, K Engle, RL Ursin… - Proceedings of the …, 2018 - National Acad Sciences
Biological sex affects adaptive immune responses, which could impact influenza infection
and vaccine efficacy. Infection of mice with 2009 H1N1 induced antibody responses, CD4+ T …

Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection

A Pizzolla, THO Nguyen, JM Smith, AG Brooks… - Science …, 2017 - science.org
Nasal epithelial tissue of the upper respiratory tract is the first site of contact by inhaled
pathogens such as influenza virus. We show that this region is key to limiting viral spread to …

[HTML][HTML] Towards effective COVID‑19 vaccines: Updates, perspectives and challenges

D Calina, AO Docea, D Petrakis… - International …, 2020 - spandidos-publications.com
In the current context of the pandemic triggered by SARS-COV-2, the immunization of the
population through vaccination is recognized as a public health priority. In the case of SARS …

Immune responses after live attenuated influenza vaccination

KGI Mohn, I Smith, H Sjursen… - Human vaccines & …, 2018 - Taylor & Francis
ABSTRACT Since 2003 (US) and 2012 (Europe) the live attenuated influenza vaccine
(LAIV) has been used as an alternative to the traditional inactivated influenza vaccines (IIV) …

Influenza vaccines: Past, present, and future

YH Kim, KJ Hong, H Kim… - Reviews in medical …, 2022 - Wiley Online Library
​ Summary Globally, infection by seasonal influenza viruses causes 3–5 million cases of
severe illness and 290,000–650,000 respiratory deaths each year. Various influenza …

Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection

BK Diallo, C Ní Chasaide, TY Wong, P Schmitt, KS Lee… - npj Vaccines, 2023 - nature.com
Current COVID-19 vaccines prevent severe disease, but do not induce mucosal immunity or
prevent infection with SARS-CoV-2, especially with recent variants. Furthermore, serum …